Genkyotex reports progress of Setanaxib phase 2 investigator initiated trials
Genkyotex provides business update and reports cash position at September 30, 2019
Genkyotex Announces First Half 2019 Results
Genkyotex Extends Conversion Period for Outstanding €1.6 Million Convertible Debt by 12 Months
Genkyotex announces positive post-hoc analysis of PBC phase 2 trial and reports cash position at june 30, 2019
The WHO recognizes NOX inhibitors as new therapeutic class and approves SETANAXIB for GKT831
Genkyotex Announces FDA Approval of Phase 2 Investigator-Initiated Trial with GKT831 in IPF
Genkyotex’s GKT831 prevents multiple complications of portal hypertension in preclinical model
Final Data Analysis of Phase 2 PBC Trial
Result of the vote on the resolutions - Combined General Meeting of June 13, 2019 at 10 am (French)
Registration Document including the Annual Financial Report 2018
Notice of Meeting - Shareholders' General Meeting of June 13, 2019 (French)
Genkyotex invites shareholders to annual general meeting on June 13, 2019
Publication of GKT831 data in the Journal of Hepatology
Genkyotex Reports Clinical Evidence of Anti-fibrotic Activity by GKT831 in Liver Fibrosis Patients
Genkyotex Conference Call at 2pm Paris time on 2nd MayGenkyotex Conference Call at 2pm Paris time on 2nd May
Genkyotex provides corporate update and reports cash position at March 31, 2019
Genkyotex to present updated interim results from Phase 2 trial of GKT831 in primary biliary cholongitis at 2019 EASL International Liver Congress (ILC)
Genkyotex reverse stock split takes effect
Genkyotex Announces Completion of 24-Week Treatment Period of its Phase 2 Trial with GKT831 in PBC
Genkyotex announces 2018 annual financial results and provides corporate update
Launch of the reverse stock split of Genkyotex shares
Genkyotex to Present Corporate Overview at Two Upcoming NASH Conferences
Genkyotex Announces Award of Grant from Cancer Research UK to Academic Partner to Further Develop NOX Research in Oncology
Genkyotex Provides Corporate Update and Reports Cash Position at December 31, 2018
Genkyotex announces the approval of reverse stock split by its shareholders and provides business update
Genkyotex announces its financial calendar for 2019
Ask us your questions
Suscribe to Newsletter
